| NCT02402166 |
Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02402166 |
Completed |
Shire |
2016-06-30 |
| NCT04085172 |
A Study to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged Release (SPD503) in Children and Adolescents Aged 6 to 17 Years With Attentiondeficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT04085172 |
Recruiting |
Shire |
2024-04-29 |
| NCT03368690 |
Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03368690 |
Completed |
Taipei Medical University |
2019-06-21 |
| NCT04416360 |
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak |
https://ClinicalTrials.gov/show/NCT04416360 |
Recruiting |
University Hospital, Toulouse |
2020-07-31 |
| NCT03363568 |
Neuroplasticity Technology for Attention-deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT03363568 |
Completed |
Boston Children’s Hospital |
2014-03-03 |
| NCT03337646 |
Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism |
https://ClinicalTrials.gov/show/NCT03337646 |
Recruiting |
JPM van Stralen Medicine Professional |
2020-10-31 |
| NCT03337425 |
Psychoeducational Groups for Adults With ADHD |
https://ClinicalTrials.gov/show/NCT03337425 |
Recruiting |
Norwegian University of Science and Technology |
2019-06-15 |
| NCT03327402 |
Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT03327402 |
Completed |
Shire |
2018-10-05 |
| NCT03326427 |
Group Dialectical Behavior Therapy as add-on Treatment for Adults With Attention Deficit/Hyperactive Disorder |
https://ClinicalTrials.gov/show/NCT03326427 |
Completed |
Hospital de Clinicas de Porto Alegre |
2018-11-24 |
| NCT03325881 |
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years |
https://ClinicalTrials.gov/show/NCT03325881 |
Completed |
Shire |
2018-06-07 |
| NCT03324581 |
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03324581 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2018-10-31 |
| NCT03289793 |
NEUROFEEDBACK on Event-Related Potential (ERP) |
https://ClinicalTrials.gov/show/NCT03289793 |
Completed |
Hospices Civils de Lyon |
2019-09-09 |
| NCT03265119 |
PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations |
https://ClinicalTrials.gov/show/NCT03265119 |
Completed |
Aevi Genomic Medicine, LLC, a Cerecor company |
2018-09-24 |
| NCT03260205 |
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT03260205 |
Completed |
Shire |
2018-10-23 |
| NCT03250013 |
Long-term Effects of Medication for ADHD |
https://ClinicalTrials.gov/show/NCT03250013 |
Recruiting |
Göteborg University |
2021-09-30 |
| NCT03220308 |
Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting |
https://ClinicalTrials.gov/show/NCT03220308 |
Completed |
Karakter Kinder- en Jeugdpsychiatrie |
2018-07-26 |
| NCT03203928 |
Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD |
https://ClinicalTrials.gov/show/NCT03203928 |
Completed |
Columbia University |
2018-01-10 |
| NCT03153488 |
Attention Deficit Hyperactivity Disorder (ADHD) Prediction of Treatment Response |
https://ClinicalTrials.gov/show/NCT03153488 |
Recruiting |
Massachusetts General Hospital |
2020-07-01 |
| NCT03136263 |
Oxytocin and Cognitive Control in Adult ADHD |
https://ClinicalTrials.gov/show/NCT03136263 |
Recruiting |
Massachusetts General Hospital |
2020-09-30 |
| NCT03115671 |
Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT03115671 |
Completed |
Institute of Mental Health, Singapore |
2018-12-31 |
| NCT03006367 |
Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD |
https://ClinicalTrials.gov/show/NCT03006367 |
Completed |
Aevi Genomic Medicine, LLC, a Cerecor company |
2017-02-26 |
| NCT02959528 |
The Effects of Working Memory Training in Children With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02959528 |
Completed |
Chang Gung Memorial Hospital |
2016-11-25 |
| NCT03231800 |
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. |
https://ClinicalTrials.gov/show/NCT03231800 |
Completed |
Sunovion |
2019-03-15 |
| NCT02951754 |
Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02951754 |
Recruiting |
Hospital de Clinicas de Porto Alegre |
2032-12-31 |
| NCT02937142 |
Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02937142 |
Active, not recruiting |
St. Olavs Hospital |
2020-01-31 |
| NCT02911194 |
a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02911194 |
Completed |
Northumbria University |
2018-09-30 |
| NCT02908802 |
Probiotic Supplement as Treatment for Students With ADHD |
https://ClinicalTrials.gov/show/NCT02908802 |
Active, not recruiting |
Tel Hai College |
2019-09-30 |
| NCT02889354 |
Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type |
https://ClinicalTrials.gov/show/NCT02889354 |
Completed |
Karolinska Institutet |
2017-06-30 |
| NCT02874690 |
Stimulant Autism Test |
https://ClinicalTrials.gov/show/NCT02874690 |
Active, not recruiting |
Children’s Hospital Medical Center, Cincinnati |
2018-10-31 |
| NCT02829970 |
Helping College Students With ADHD Lead Healthier Lifestyles |
https://ClinicalTrials.gov/show/NCT02829970 |
Completed |
University of Maryland, College Park |
2019-09-30 |
| NCT02828644 |
Software Treatment for Actively Reducing Severity of ADHD - Follow Up |
https://ClinicalTrials.gov/show/NCT02828644 |
Completed |
Akili Interactive Labs, Inc. |
2017-12-31 |
| NCT02816151 |
Children Toxine Botulinum Detrusor Injection in Neurogenic Vesical Hyperactivity Syndrom: Non Inferiority Multicenter Controlled Therapeutic Study Between Two Reported Weight’s Doses |
https://ClinicalTrials.gov/show/NCT02816151 |
Completed |
CHU de Reims |
2016-05-31 |
| NCT02808104 |
Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02808104 |
Completed |
NLS-1 Pharma Inc. |
2017-03-28 |
| NCT02807870 |
Early Interventions in Children With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02807870 |
Enrolling by invitation |
University of Sao Paulo |
2019-12-31 |
| NCT02803229 |
Treatment of Cannabis Use Disorder Among Adults With Comorbid Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02803229 |
Completed |
New York State Psychiatric Institute |
2020-06-30 |
| NCT02795637 |
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT02795637 |
Completed |
Sunovion |
2016-11-30 |
| NCT02788851 |
The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02788851 |
Active, not recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2018-12-31 |
| NCT02737033 |
Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02737033 |
Recruiting |
Hospital de Clinicas de Porto Alegre |
2021-03-31 |
| NCT02737020 |
Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02737020 |
Recruiting |
Hospital de Clinicas de Porto Alegre |
2021-03-31 |
| NCT02736656 |
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 Extended Release (ER) |
https://ClinicalTrials.gov/show/NCT02736656 |
Active, not recruiting |
Supernus Pharmaceuticals, Inc. |
2021-06-30 |
| NCT02734693 |
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. |
https://ClinicalTrials.gov/show/NCT02734693 |
Completed |
Sunovion |
2017-02-28 |
| NCT02732496 |
Computerized Working Memory Training in Children With ADHD and Comorbid Tourette Syndrome |
https://ClinicalTrials.gov/show/NCT02732496 |
Completed |
Massachusetts General Hospital |
2017-11-03 |
| NCT02728011 |
Pilot Trial Comparing Computerised Cognitive Exercises to Tetris in Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT02728011 |
Completed |
Region Syddanmark |
2010-12-31 |
| NCT02716324 |
Communication to Improve Shared Decision-Making in ADHD |
https://ClinicalTrials.gov/show/NCT02716324 |
Completed |
Children’s Hospital of Philadelphia |
2018-05-09 |
| NCT02699086 |
A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02699086 |
Recruiting |
BioLite, Inc. |
2020-05-31 |
| NCT02688959 |
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02688959 |
Recruiting |
University of Wisconsin, Madison |
2021-06-30 |
| NCT02681575 |
Meta-cognitive Functional Intervention for Adults With ADHD: A Pilot Efficacy Study |
https://ClinicalTrials.gov/show/NCT02681575 |
Completed |
Hadassah Medical Organization |
2017-07-31 |
| NCT02675400 |
Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too) |
https://ClinicalTrials.gov/show/NCT02675400 |
Completed |
Seattle Children’s Hospital |
2018-08-31 |
| NCT02674633 |
Software Treatment for Actively Reducing Severity of ADHD |
https://ClinicalTrials.gov/show/NCT02674633 |
Completed |
Akili Interactive Labs, Inc. |
2017-07-31 |
| NCT02655276 |
Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children |
https://ClinicalTrials.gov/show/NCT02655276 |
Completed |
University Hospital Freiburg |
2016-05-31 |
| NCT02642666 |
The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children |
https://ClinicalTrials.gov/show/NCT02642666 |
Completed |
University of California, Davis |
2016-03-31 |
| NCT02635035 |
Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT |
https://ClinicalTrials.gov/show/NCT02635035 |
Completed |
NYU Langone Health |
2019-01-09 |
| NCT02604407 |
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02604407 |
Completed |
Shire |
2016-03-31 |
| NCT02588365 |
Brain Training in Children With/At-risk for Attention-Deficit/Hyperactivity Disorder and Executive Function Impairment |
https://ClinicalTrials.gov/show/NCT02588365 |
Completed |
Stanford University |
2018-12-31 |
| NCT02578030 |
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD |
https://ClinicalTrials.gov/show/NCT02578030 |
Completed |
Shire |
2015-11-10 |
| NCT02566824 |
Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02566824 |
Recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2020-08-31 |
| NCT02560454 |
Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02560454 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2018-09-30 |
| NCT02558790 |
L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD |
https://ClinicalTrials.gov/show/NCT02558790 |
Completed |
Massachusetts General Hospital |
2017-10-31 |
| NCT02547428 |
Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02547428 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2016-05-31 |
| NCT02536105 |
PK/PD Pediatric ADHD Classroom Study |
https://ClinicalTrials.gov/show/NCT02536105 |
Completed |
Massachusetts General Hospital |
2018-07-31 |
| NCT02520388 |
A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting |
https://ClinicalTrials.gov/show/NCT02520388 |
Completed |
Ironshore Pharmaceuticals and Development, Inc |
2016-04-30 |
| NCT02489279 |
Training Attentional Awareness and Control in ADHD |
https://ClinicalTrials.gov/show/NCT02489279 |
Completed |
Think Now Incorporated |
2016-12-31 |
| NCT02466425 |
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02466425 |
Completed |
Shire |
2016-02-16 |
| NCT02466386 |
Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02466386 |
Completed |
Shire |
2019-12-30 |
| NCT02457819 |
Dasotraline Pediatric Extension Study |
https://ClinicalTrials.gov/show/NCT02457819 |
Completed |
Sunovion |
2017-02-02 |
| NCT02428088 |
Dasotraline Pediatric ADHD Study |
https://ClinicalTrials.gov/show/NCT02428088 |
Completed |
Sunovion |
2016-07-31 |
| NCT02358941 |
Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT02358941 |
Completed |
University of Zurich |
2017-03-31 |
| NCT02333149 |
Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population |
https://ClinicalTrials.gov/show/NCT02333149 |
Active, not recruiting |
University of Alberta |
2022-12-31 |
| NCT02327013 |
Investigating the Effect of Vortioxetine in Adult ADHD Patients |
https://ClinicalTrials.gov/show/NCT02327013 |
Completed |
H. Lundbeck A/S |
2016-09-30 |
| NCT02305134 |
Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial |
https://ClinicalTrials.gov/show/NCT02305134 |
Completed |
Chiba University |
2019-03-31 |
| NCT02286817 |
Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02286817 |
Completed |
Aevi Genomic Medicine, LLC, a Cerecor company |
2015-05-31 |
| NCT02286349 |
Non Invasive Brain Stimulation Effects on Attentional Performance in ADHD Adults |
https://ClinicalTrials.gov/show/NCT02286349 |
Completed |
Universidade Federal de Pernambuco |
2015-08-31 |
| NCT02276209 |
Dasotraline Adult ADHD Study |
https://ClinicalTrials.gov/show/NCT02276209 |
Completed |
Sunovion |
2016-09-30 |
| NCT02257216 |
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02257216 |
Completed |
Enzymotec |
2017-05-31 |
| NCT02255513 |
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD |
https://ClinicalTrials.gov/show/NCT02255513 |
Completed |
Ironshore Pharmaceuticals and Development, Inc |
2014-10-31 |
| NCT02253745 |
Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02253745 |
Completed |
Vernalis (R&D) Ltd |
2014-03-31 |
| NCT02251743 |
Double-Blind 2-Site Randomized Clinical Trial of Neurofeedback for ADHD |
https://ClinicalTrials.gov/show/NCT02251743 |
Active, not recruiting |
Ohio State University |
2019-04-30 |
| NCT02248948 |
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children |
https://ClinicalTrials.gov/show/NCT02248948 |
Completed |
Laboratorios Ordesa |
2016-07-31 |
| NCT02217371 |
Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity |
https://ClinicalTrials.gov/show/NCT02217371 |
Completed |
University Hospital, Bordeaux |
2017-05-31 |
| NCT02204410 |
Omega-3 Supplementation to ADHD Medication in Children |
https://ClinicalTrials.gov/show/NCT02204410 |
Completed |
Massachusetts General Hospital |
2016-05-31 |
| NCT02195167 |
Dasotraline SEP360-105 Pediatric PK/PD Study |
https://ClinicalTrials.gov/show/NCT02195167 |
Completed |
Sunovion |
2015-03-31 |
| NCT02172183 |
CBT Group for Adolescents With ADHD: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT02172183 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2014-03-31 |
| NCT02167048 |
Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD |
https://ClinicalTrials.gov/show/NCT02167048 |
Recruiting |
University of British Columbia |
2019-12-31 |
| NCT02160262 |
Open-label Safety Study in Adults With ADHD |
https://ClinicalTrials.gov/show/NCT02160262 |
Completed |
Sunovion |
2016-05-31 |
| NCT02151396 |
Effect of Working Memory Training on ADHD Brain Function |
https://ClinicalTrials.gov/show/NCT02151396 |
Completed |
Hartford Hospital |
2013-02-28 |
| NCT02142140 |
Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02142140 |
Active, not recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2019-02-28 |
| NCT02114632 |
Supplementation of Polyunsaturated Fatty Acids in Children With Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02114632 |
Completed |
Medical University of Warsaw |
2012-05-31 |
| NCT02105142 |
Comparative Effectiveness of Primary Care-based Interventions for Pediatric ADHD |
https://ClinicalTrials.gov/show/NCT02105142 |
Completed |
Indiana University |
2015-09-30 |
| NCT02096952 |
Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD |
https://ClinicalTrials.gov/show/NCT02096952 |
Completed |
Massachusetts General Hospital |
2018-01-31 |
| NCT02086864 |
A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD |
https://ClinicalTrials.gov/show/NCT02086864 |
Active, not recruiting |
University of Toronto |
2020-06-30 |
| NCT02083783 |
TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02083783 |
Completed |
Tris Pharma, Inc. |
2014-10-31 |
| NCT02059642 |
A 6 Week Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD ( Attention Deficit/Hyperactivity ) |
https://ClinicalTrials.gov/show/NCT02059642 |
Completed |
Alcobra Ltd. |
2014-09-30 |
| NCT01275378 |
Comparative Effectiveness Research for Two Medical Home Models for Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01275378 |
Completed |
Boston Medical Center |
2014-06-30 |
| NCT01270555 |
Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults |
https://ClinicalTrials.gov/show/NCT01270555 |
Completed |
Massachusetts General Hospital |
2001-07-31 |
| NCT01269463 |
Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting |
https://ClinicalTrials.gov/show/NCT01269463 |
Completed |
Rhodes Pharmaceuticals, L.P. |
2011-06-30 |
| NCT01986062 |
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting |
https://ClinicalTrials.gov/show/NCT01986062 |
Completed |
Arbor Pharmaceuticals, Inc. |
2014-05-31 |
| NCT01985581 |
Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD |
https://ClinicalTrials.gov/show/NCT01985581 |
Completed |
JPM van Stralen Medicine Professional |
2015-03-31 |
| NCT01982422 |
Developmental Origins of Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01982422 |
Completed |
Oregon Health and Science University |
2014-05-31 |
| NCT01968512 |
Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01968512 |
Completed |
Federal University of Bahia |
2014-04-30 |
| NCT01967485 |
Text Messaging Adherence to Stimulant Medication |
https://ClinicalTrials.gov/show/NCT01967485 |
Completed |
Massachusetts General Hospital |
2016-08-31 |
| NCT01943539 |
Cognitive ADHD Videogame Exploratory Study |
https://ClinicalTrials.gov/show/NCT01943539 |
Completed |
Akili Interactive Labs, Inc. |
2015-05-31 |
| NCT01940978 |
A Study of Combination Therapy in Children With ADHD |
https://ClinicalTrials.gov/show/NCT01940978 |
Completed |
Sears, Douglas, M.D. |
2015-03-31 |
| NCT01912352 |
Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01912352 |
Completed |
Seoul National University |
2013-04-30 |
| NCT01907360 |
Phase I/II Single Center, Open-Label Study Examining Image Result for Pharmacokinetics of 2 Modified-Release Formulations of MPH in Adolescent/Pediatric With ADHD |
https://ClinicalTrials.gov/show/NCT01907360 |
Completed |
Ironshore Pharmaceuticals and Development, Inc |
2013-10-31 |
| NCT01886469 |
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01886469 |
Completed |
Ironshore Pharmaceuticals and Development, Inc |
2013-09-30 |
| NCT01876524 |
tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients |
https://ClinicalTrials.gov/show/NCT01876524 |
Completed |
Spanish Foundation for Neurometrics Development |
2014-08-31 |
| NCT01873729 |
An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. |
https://ClinicalTrials.gov/show/NCT01873729 |
Completed |
Massachusetts General Hospital |
2016-06-30 |
| NCT01855984 |
Tocotrienols for School-going Children With ADHD |
https://ClinicalTrials.gov/show/NCT01855984 |
Completed |
RCSI & UCD Malaysia Campus |
2013-06-30 |
| NCT01853280 |
L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults |
https://ClinicalTrials.gov/show/NCT01853280 |
Completed |
Massachusetts General Hospital |
2017-02-28 |
| NCT01835548 |
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01835548 |
Completed |
Neos Therapeutics, Inc |
2014-07-31 |
| NCT01835093 |
An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01835093 |
Completed |
Chiba University |
2013-12-31 |
| NCT01831622 |
Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01831622 |
Completed |
University of Oslo |
2015-06-30 |
| NCT01807299 |
The Effect of Physical Training and the Omega 3 Consumption on Attention Deficit Hyperactivity Disorder in Children |
https://ClinicalTrials.gov/show/NCT01807299 |
Completed |
Federal University of São Paulo |
2013-03-31 |
| NCT01796262 |
The Effects of DHA on Attention Deficit and Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01796262 |
Completed |
IRCCS Eugenio Medea |
2015-02-28 |
| NCT01738334 |
Effects Of The Mindfulness Meditation Practices On Cognition |
https://ClinicalTrials.gov/show/NCT01738334 |
Completed |
Federal University of São Paulo |
2012-02-29 |
| NCT01709695 |
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT01709695 |
Completed |
Icahn School of Medicine at Mount Sinai |
2013-12-31 |
| NCT01694667 |
Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder |
https://ClinicalTrials.gov/show/NCT01694667 |
Completed |
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
2012-12-31 |
| NCT01692782 |
Adult Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01692782 |
Completed |
Sunovion |
2013-11-30 |
| NCT01686724 |
Study of the Collaborative Life Skills Program |
https://ClinicalTrials.gov/show/NCT01686724 |
Completed |
University of California, San Francisco |
2015-11-30 |
| NCT01678209 |
Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach |
https://ClinicalTrials.gov/show/NCT01678209 |
Completed |
Icahn School of Medicine at Mount Sinai |
2018-04-30 |
| NCT01675869 |
Executive Function/Metacognitive Training for At-Risk Preschoolers |
https://ClinicalTrials.gov/show/NCT01675869 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2015-06-30 |
| NCT01675804 |
Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD |
https://ClinicalTrials.gov/show/NCT01675804 |
Completed |
Allameh Tabatabai University |
2012-04-30 |
| NCT01660464 |
Guided Self-Help for Parents of Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01660464 |
Completed |
University of Cologne |
2013-11-30 |
| NCT01654250 |
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01654250 |
Completed |
Pfizer |
2012-10-31 |
| NCT01583829 |
Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01583829 |
Completed |
Tufts Medical Center |
2012-12-31 |
| NCT01557595 |
Blue Wavelength Light-blocking Glasses in ADHD-Insomnia |
https://ClinicalTrials.gov/show/NCT01557595 |
Completed |
University of Alabama at Birmingham |
2012-06-30 |
| NCT01554462 |
The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHD |
https://ClinicalTrials.gov/show/NCT01554462 |
Completed |
Unilever R&D |
2013-01-31 |
| NCT01554046 |
The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01554046 |
Recruiting |
Sheba Medical Center |
2022-03-31 |
| NCT01553695 |
Adults With Attention Deficit Hyperactivity Disorder (ADHD): Validation of a Clinical Interview and Screening Instruments in French |
https://ClinicalTrials.gov/show/NCT01553695 |
Completed |
Centre Hospitalier Universitaire de Nice |
2012-03-31 |
| NCT01552915 |
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01552915 |
Completed |
Shire |
2014-01-31 |
| NCT01552902 |
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01552902 |
Completed |
Shire |
2014-05-31 |
| NCT01547702 |
Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01547702 |
Completed |
Dalhousie University |
2013-05-31 |
| NCT01542528 |
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01542528 |
Completed |
Yale University |
2016-07-31 |
| NCT01536210 |
Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder) |
https://ClinicalTrials.gov/show/NCT01536210 |
Completed |
Yuyu Pharma, Inc. |
2012-08-31 |
| NCT01500694 |
Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe |
https://ClinicalTrials.gov/show/NCT01500694 |
Completed |
Shire |
2015-09-15 |
| NCT01487967 |
Preference and Goal Directed Attention Deficit Hyperactivity Disorder Care- Pilot Study |
https://ClinicalTrials.gov/show/NCT01487967 |
Completed |
Children’s Hospital of Philadelphia |
2015-06-30 |
| NCT01472991 |
Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01472991 |
Completed |
Targacept Inc. |
2012-07-31 |
| NCT01462032 |
Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01462032 |
Completed |
Queens College, The City University of New York |
2014-03-31 |
| NCT01458340 |
A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01458340 |
Completed |
Theravance Biopharma |
2013-10-31 |
| NCT01439126 |
Efficacy & Safety of KAPVAYâ„¢ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01439126 |
Completed |
Concordia Pharmaceuticals Inc., Barbados |
2012-10-31 |
| NCT01431235 |
CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders |
https://ClinicalTrials.gov/show/NCT01431235 |
Completed |
Arkin |
2016-12-31 |
| NCT01415440 |
Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD |
https://ClinicalTrials.gov/show/NCT01415440 |
Completed |
New York State Psychiatric Institute |
2018-06-30 |
| NCT01388530 |
Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01388530 |
Completed |
University of California, Los Angeles |
2012-12-31 |
| NCT01369459 |
Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01369459 |
Completed |
The National Center on Addiction and Substance Abuse at Columbia University |
2014-03-31 |
| NCT01364662 |
A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01364662 |
Completed |
Supernus Pharmaceuticals, Inc. |
2012-10-31 |
| NCT01363544 |
Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01363544 |
Completed |
VU University of Amsterdam |
2015-01-31 |
| NCT01357993 |
A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01357993 |
Completed |
Janssen Pharmaceutical K.K. |
2013-03-31 |
| NCT01352468 |
Development of a Multi-faceted Cognitive Training Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01352468 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-12-31 |
| NCT01351246 |
Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01351246 |
Completed |
University of Cologne |
2014-02-28 |
| NCT01351064 |
Using Computers to Assist in the Diagnosis and Treatment of Attention-deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01351064 |
Completed |
Indiana University |
2012-07-31 |
| NCT01344044 |
Brain-Computer Interface (BCI) Based Intervention for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01344044 |
Completed |
National Healthcare Group, Singapore |
2016-05-13 |
| NCT01338818 |
Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01338818 |
Completed |
Novartis |
2013-02-28 |
| NCT01329510 |
Sleep and Nocturnal Melatonin in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01329510 |
Completed |
Assaf-Harofeh Medical Center |
2006-12-31 |
| NCT01328756 |
Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01328756 |
Completed |
Shire |
2014-09-30 |
| NCT01323192 |
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01323192 |
Completed |
Janssen Pharmaceutical K.K. |
2012-04-30 |
| NCT01322646 |
A Randomized Trial of Interventions for Teenage Drivers With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01322646 |
Completed |
State University of New York at Buffalo |
2015-06-30 |
| NCT01320098 |
Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers |
https://ClinicalTrials.gov/show/NCT01320098 |
Completed |
NYU Langone Health |
2014-11-30 |
| NCT04408521 |
Effects of a Novel Neurofeedback Protocol on ADHD Subcomponents |
https://ClinicalTrials.gov/show/NCT04408521 |
Enrolling by invitation |
University Hospital, Geneva |
2023-04-30 |
| NCT04378517 |
Family Strength Oriented Therapeutic Conversation for Parents of Adolescent With ADHD: Pilot Study |
https://ClinicalTrials.gov/show/NCT04378517 |
Completed |
University of Iceland |
2019-02-20 |
| NCT04362982 |
Αn Information System for Symptom Diagnosis and Improvement of Attention Deficit Hyperactivity Disorder (ADHD360) |
https://ClinicalTrials.gov/show/NCT04362982 |
Recruiting |
Aristotle University Of Thessaloniki |
2021-04-30 |
| NCT04355065 |
The Secret Trail of Moon (Serious Videogame) and Chess on ADHD: a Clinal Trial |
https://ClinicalTrials.gov/show/NCT04355065 |
Recruiting |
Puerta de Hierro University Hospital |
2020-11-30 |
| NCT04270526 |
Minimizing Pain During Office Intradetrussor Botox Injection |
https://ClinicalTrials.gov/show/NCT04270526 |
Recruiting |
Boston Urogynecology Associates |
2021-01-31 |
| NCT04229251 |
Online Mindfulness-Based Intervention for ADHD |
https://ClinicalTrials.gov/show/NCT04229251 |
Enrolling by invitation |
Universiti Tunku Abdul Rahman |
2020-12-31 |
| NCT04196881 |
Effect of Attention Deficit Hyperactivity Disorder Knowledge Improvement Program on Male Primary School Teachers |
https://ClinicalTrials.gov/show/NCT04196881 |
Active, not recruiting |
King Khalid University |
2020-01-01 |
| NCT04189575 |
A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting |
https://ClinicalTrials.gov/show/NCT04189575 |
Recruiting |
Massachusetts General Hospital |
2020-06-30 |
| NCT04189562 |
A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medications in Children With ADHD |
https://ClinicalTrials.gov/show/NCT04189562 |
Recruiting |
Massachusetts General Hospital |
2021-02-28 |
| NCT04189536 |
An SMS Intervention to Improve Adherence to Stimulant Medications in Adults With ADHD |
https://ClinicalTrials.gov/show/NCT04189536 |
Active, not recruiting |
Massachusetts General Hospital |
2020-09-30 |
| NCT04167995 |
Assessment of Probiotics Lactobacillus in the Management of Attention Deficit Hyperactive Disorder |
https://ClinicalTrials.gov/show/NCT04167995 |
Recruiting |
Ain Shams University |
2019-11-09 |
| NCT04152629 |
Real World Evidence of the Efficacy and Safety of FOQUEST |
https://ClinicalTrials.gov/show/NCT04152629 |
Recruiting |
Purdue Pharma, Canada |
2020-08-31 |
| NCT04143217 |
Open-label Study to Evaluate Long-Term Safety and Efficacy of SPN-812 in Adults With ADHD |
https://ClinicalTrials.gov/show/NCT04143217 |
Recruiting |
Supernus Pharmaceuticals, Inc. |
2021-07-31 |
| NCT04081363 |
Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT04081363 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2019-12-21 |
| NCT04065906 |
Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT04065906 |
Recruiting |
Xijing Hospital |
2019-12-31 |
| NCT04003740 |
TDCS for the Treatment of Inattention Symptoms in Adult ADHD Patients |
https://ClinicalTrials.gov/show/NCT04003740 |
Recruiting |
Hospital de Clinicas de Porto Alegre |
2021-07-01 |
| NCT03949413 |
Correlation Between Balance and Attention in Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03949413 |
Completed |
Delta University for Science and Technology |
2018-11-28 |
| NCT03861585 |
Emotional Information Processing in Attention Deficit Disorder With or Without Hyperactivity |
https://ClinicalTrials.gov/show/NCT03861585 |
Completed |
Fondation Lenval |
2020-03-11 |
| NCT03849807 |
Chiropractic Care on Behavior, Neurological Function and Quality of Life in ADHD Children - A Pilot Study |
https://ClinicalTrials.gov/show/NCT03849807 |
Completed |
Riphah International University |
2019-06-01 |
| NCT03844269 |
Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01 |
https://ClinicalTrials.gov/show/NCT03844269 |
Recruiting |
Akili Interactive Labs, Inc. |
2020-01-01 |
| NCT03788902 |
OT and Social Cognition in Children With ADHD: Impact of MPH |
https://ClinicalTrials.gov/show/NCT03788902 |
Completed |
Shalvata Mental Health Center |
2016-12-01 |
| NCT03730194 |
A SMART Design to Improve Sleep Disturbance in Adolescents With Neurodevelopmental Disorders |
https://ClinicalTrials.gov/show/NCT03730194 |
Recruiting |
University of Nebraska |
2022-01-31 |
| NCT03709940 |
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT03709940 |
Completed |
King’s College London |
2015-01-15 |
| NCT03678844 |
Taekwondo Practice in Adolescents With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03678844 |
Completed |
University of Genova |
2017-01-01 |
| NCT03663179 |
Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT03663179 |
Completed |
University of Pennsylvania |
2019-03-31 |
| NCT03659929 |
Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate |
https://ClinicalTrials.gov/show/NCT03659929 |
Completed |
Arbor Pharmaceuticals, Inc. |
2019-04-18 |
| NCT03610464 |
Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years |
https://ClinicalTrials.gov/show/NCT03610464 |
Completed |
Tris Pharma, Inc. |
2018-05-23 |
| NCT03609619 |
PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations |
https://ClinicalTrials.gov/show/NCT03609619 |
Completed |
Aevi Genomic Medicine, LLC, a Cerecor company |
2018-11-23 |
| NCT03605849 |
A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03605849 |
Active, not recruiting |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2021-06-30 |
| NCT03605836 |
A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03605836 |
Active, not recruiting |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2020-06-30 |
| NCT03605680 |
A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03605680 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2020-04-11 |
| NCT03597503 |
Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment |
https://ClinicalTrials.gov/show/NCT03597503 |
Recruiting |
Supernus Pharmaceuticals, Inc. |
2020-07-29 |
| NCT03595826 |
Co Morbid Attention Deficit and Hyperactivity Disorder(ADHD) and Developmental Co Ordination Disorder (DCD) |
https://ClinicalTrials.gov/show/NCT03595826 |
Recruiting |
University of KwaZulu |
2019-05-30 |
| NCT03565250 |
A Study of Identity Building in Children With ADHD |
https://ClinicalTrials.gov/show/NCT03565250 |
Recruiting |
University Hospital, Caen |
2020-08-04 |
| NCT03547843 |
The Effects of Peer Co-led Educational Group Intervention for Adults With Attention-Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03547843 |
Recruiting |
Norwegian University of Science and Technology |
2021-12-31 |
| NCT03542643 |
Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD |
https://ClinicalTrials.gov/show/NCT03542643 |
Completed |
China Medical University Hospital |
2017-12-11 |
| NCT03533556 |
Effects of L-theanine and Caffeine on Attention and Attention-related Brain Activity of Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03533556 |
Completed |
Texas Tech University |
2018-08-31 |
| NCT03481959 |
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity |
https://ClinicalTrials.gov/show/NCT03481959 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2022-05-30 |
| NCT03469180 |
Comparison of Treadmill and Whole Body Vibration Training in Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT03469180 |
Completed |
Bezmialem Vakif University |
2018-06-01 |
| NCT03468465 |
Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome |
https://ClinicalTrials.gov/show/NCT03468465 |
Active, not recruiting |
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia |
2019-03-31 |
| NCT03446885 |
Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD |
https://ClinicalTrials.gov/show/NCT03446885 |
Recruiting |
State University of New York at Buffalo |
2018-12-31 |
| NCT03440346 |
Biomarker Research in ADHD: the Impact of Nutrition |
https://ClinicalTrials.gov/show/NCT03440346 |
Completed |
Wageningen University |
2019-06-21 |
| NCT01259492 |
Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01259492 |
Completed |
Novartis |
2012-08-31 |
| NCT01244490 |
Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01244490 |
Completed |
Shire |
2013-05-31 |
| NCT01239030 |
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT01239030 |
Completed |
Rhodes Pharmaceuticals, L.P. |
2012-02-29 |
| NCT01238822 |
Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01238822 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2009-06-30 |
| NCT01238575 |
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder |
https://ClinicalTrials.gov/show/NCT01238575 |
Completed |
Yale University |
2014-03-31 |
| NCT01228604 |
Cost-Effectiveness Study Of The Treatment Of Attention Deficit/Hyperactivity Disorder In Brazil |
https://ClinicalTrials.gov/show/NCT01228604 |
Completed |
Hospital de Clinicas de Porto Alegre |
2013-12-31 |
| NCT01176136 |
Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01176136 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2012-06-30 |
| NCT01174355 |
A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01174355 |
Completed |
NeuroDerm Ltd. |
2017-06-30 |
| NCT01161719 |
Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01161719 |
Completed |
University of California, Davis |
2009-06-30 |
| NCT01160874 |
Sleepiness and Driving Performances in Adults With Attention-Deficit/ Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01160874 |
Completed |
University Hospital, Bordeaux |
2013-07-31 |
| NCT01146002 |
Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine |
https://ClinicalTrials.gov/show/NCT01146002 |
Completed |
Neurology Group of Bergen County, P.A. |
2013-02-28 |
| NCT01141634 |
A Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01141634 |
Completed |
University of Toronto |
2012-12-31 |
| NCT01106430 |
Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate |
https://ClinicalTrials.gov/show/NCT01106430 |
Completed |
Shire |
2012-07-31 |
| NCT01098058 |
Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01098058 |
Completed |
South London and Maudsley NHS Foundation Trust |
2014-09-30 |
| NCT01081145 |
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01081145 |
Completed |
Shire |
2013-06-30 |
| NCT01081132 |
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl |
https://ClinicalTrials.gov/show/NCT01081132 |
Completed |
Shire |
2013-05-31 |
| NCT01074294 |
Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01074294 |
Completed |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2011-06-30 |
| NCT01070394 |
Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse) |
https://ClinicalTrials.gov/show/NCT01070394 |
Completed |
NYU Langone Health |
2012-07-31 |
| NCT01069523 |
Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01069523 |
Completed |
The University of Texas Health Science Center at San Antonio |
2011-08-31 |
| NCT01065259 |
Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children |
https://ClinicalTrials.gov/show/NCT01065259 |
Completed |
Peking University |
2010-12-31 |
| NCT01063153 |
Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials |
https://ClinicalTrials.gov/show/NCT01063153 |
Completed |
Massachusetts General Hospital |
2012-02-29 |
| NCT01060150 |
An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01060150 |
Completed |
Janssen Korea, Ltd., Korea |
2010-04-30 |
| NCT01056016 |
Disseminating a Model Intervention to Promote Improved Attention-deficit Hyperactivity Disorder (ADHD) Care in the Community |
https://ClinicalTrials.gov/show/NCT01056016 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2010-07-31 |
| NCT01055119 |
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT01055119 |
Completed |
University of Ulm |
2012-09-30 |
| NCT01040702 |
The Effect of Methylphenidate on Decision-making Ability of Attention Deficit Hyperactivity Disorder (ADHD) Adults |
https://ClinicalTrials.gov/show/NCT01040702 |
Completed |
Shalvata Mental Health Center |
2009-08-31 |
| NCT01022229 |
The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01022229 |
Completed |
The Canadian College of Naturopathic Medicine |
2015-11-30 |
| NCT01012778 |
Implementation of Climb Up Program for Children With Attention Deficit Hyperactivity Disorder (ADHD) and Dyslexia in a School in India |
https://ClinicalTrials.gov/show/NCT01012778 |
Completed |
Climb Up Kids |
2015-08-31 |
| NCT01012622 |
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01012622 |
Completed |
Janssen Korea, Ltd., Korea |
2009-08-31 |
| NCT01010750 |
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT01010750 |
Completed |
Shire |
2010-02-28 |
| NCT00997984 |
Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) |
https://ClinicalTrials.gov/show/NCT00997984 |
Completed |
Shire |
2010-10-31 |
| NCT00995085 |
Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects |
https://ClinicalTrials.gov/show/NCT00995085 |
Completed |
Alcobra Ltd. |
2010-10-31 |
| NCT00989950 |
Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD |
https://ClinicalTrials.gov/show/NCT00989950 |
Completed |
Cox Health Systems |
2011-02-28 |
| NCT00983814 |
Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa |
https://ClinicalTrials.gov/show/NCT00983814 |
Completed |
Chelsea Therapeutics |
2011-05-31 |
| NCT00969618 |
A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00969618 |
Completed |
Eli Lilly and Company |
2012-01-31 |
| NCT00962104 |
Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00962104 |
Completed |
Eli Lilly and Company |
2011-02-28 |
| NCT00956605 |
A Trial of Computer-based Attention-training Systems in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00956605 |
Completed |
Tufts Medical Center |
2007-06-30 |
| NCT00947973 |
Comparing School Based Interventions for Adolescents With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00947973 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-12-31 |
| NCT00940693 |
Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD) |
https://ClinicalTrials.gov/show/NCT00940693 |
Completed |
Université de Montréal |
2010-12-31 |
| NCT00938743 |
Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine |
https://ClinicalTrials.gov/show/NCT00938743 |
Completed |
Central Institute of Mental Health, Mannheim |
2009-12-31 |
| NCT00937469 |
Social Skills Training and Standard Treatment Versus Standard Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00937469 |
Completed |
Region Zealand |
2011-07-31 |
| NCT00937040 |
Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00937040 |
Completed |
Ortho-McNeil Janssen Scientific Affairs, LLC |
2010-02-28 |
| NCT00936299 |
Bupropion for ADHD in Adolescents With Substance Use Disorder |
https://ClinicalTrials.gov/show/NCT00936299 |
Completed |
University of Colorado, Denver |
2013-05-31 |
| NCT00930449 |
Effects Of A Computerized Working Memory Training Program On Attention, Working Memory, And Academics, In Adolescents With Severe ADHD/LD |
https://ClinicalTrials.gov/show/NCT00930449 |
Completed |
The Hospital for Sick Children |
2011-01-31 |
| NCT00928148 |
The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00928148 |
Completed |
Shire |
NA |
| NCT00922636 |
A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00922636 |
Completed |
Eli Lilly and Company |
2010-12-31 |
| NCT00918567 |
Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD |
https://ClinicalTrials.gov/show/NCT00918567 |
Completed |
State University of New York at Buffalo |
2008-05-31 |
| NCT00904670 |
Quillivant Oral Suspension (Quillivant XR) in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00904670 |
Completed |
Pfizer |
2009-08-31 |
| NCT00895908 |
Reducing Attention Deficit Hyperactivity Disorder in Kindergarten and Pre-Kindergarten Children |
https://ClinicalTrials.gov/show/NCT00895908 |
Completed |
Penn State University |
2012-04-30 |
| NCT00890292 |
A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00890292 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2009-12-31 |
| NCT00890240 |
A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00890240 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2009-11-30 |
| NCT00889915 |
Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study) |
https://ClinicalTrials.gov/show/NCT00889915 |
Completed |
Duke University |
2009-12-31 |
| NCT00886483 |
Pilot Feasibility Study of Neurofeedback for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00886483 |
Completed |
Ohio State University |
2010-09-30 |
| NCT00880217 |
A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00880217 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2010-01-31 |
| NCT00877487 |
Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00877487 |
Completed |
Shire |
2010-09-30 |
| NCT00874536 |
Omega-3 Supplementation and Attention-deficit-hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00874536 |
Completed |
Hadassah Medical Organization |
2011-06-30 |
| NCT00867451 |
Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00867451 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2011-06-30 |
| NCT00866996 |
Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00866996 |
Completed |
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. |
NA |
| NCT00863499 |
International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00863499 |
Active, not recruiting |
BRC Operations Pty. Ltd. |
2019-12-31 |
| NCT00857220 |
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia |
https://ClinicalTrials.gov/show/NCT00857220 |
Completed |
Sunovion |
2011-10-31 |
| NCT00856973 |
Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia |
https://ClinicalTrials.gov/show/NCT00856973 |
Completed |
Sunovion |
2011-07-31 |
| NCT00856063 |
Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00856063 |
Completed |
University of Arizona |
2009-12-31 |
| NCT00844753 |
Atomoxetine, Placebo and Parent Management Training in Autism |
https://ClinicalTrials.gov/show/NCT00844753 |
Completed |
University of Rochester |
2014-04-30 |
| NCT00842127 |
Genetic Polymorphism and OROS-Methylphenidate Treatment in Attention Deficit Hyperactivity Disorder(ADHD) |
https://ClinicalTrials.gov/show/NCT00842127 |
Completed |
Bundang CHA Hospital |
2008-08-31 |
| NCT00834821 |
Effectiveness of a Behavioral Treatment Program for Attention Deficit Hyperactivity Disorder, Inattentive Type |
https://ClinicalTrials.gov/show/NCT00834821 |
Completed |
University of California, San Francisco |
2013-01-03 |
| NCT00830700 |
Children’s Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study |
https://ClinicalTrials.gov/show/NCT00830700 |
Completed |
Seattle Children’s Hospital |
2013-02-28 |
| NCT00829881 |
Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00829881 |
Completed |
P2D, Inc. |
2009-12-31 |
| NCT02783105 |
Effects of Early Musical Intervention on Prevalence and Severity of Paroxysmal Sympathetic Hyperactivity After Severe Traumatic Brain Injury |
https://ClinicalTrials.gov/show/NCT02783105 |
Recruiting |
University Hospital, Strasbourg, France |
2020-06-30 |
| NCT02493777 |
A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting |
https://ClinicalTrials.gov/show/NCT02493777 |
Completed |
Ironshore Pharmaceuticals and Development, Inc |
2016-02-29 |
| NCT00807222 |
Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00807222 |
Completed |
Clinical Study Centers, LLC |
2008-08-31 |
| NCT01933880 |
A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants |
https://ClinicalTrials.gov/show/NCT01933880 |
Completed |
Xian-Janssen Pharmaceutical Ltd. |
2010-11-30 |
| NCT01740206 |
Should Chronic Stimulant Medications be Continued Preoperatively in Patients With Attention Deficit Hyperactivity Disorder(ADHD) |
https://ClinicalTrials.gov/show/NCT01740206 |
Completed |
Nationwide Children’s Hospital |
2015-12-31 |
| NCT00802490 |
Effectiveness of a Electroencephalogram (EEG) Biofeedback for the Treatment of ADHD |
https://ClinicalTrials.gov/show/NCT00802490 |
Completed |
National Healthcare Group, Singapore |
2011-12-31 |
| NCT02580890 |
Role of Transcranial Direct Current Stimulation (tDCS) in Patients With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT02580890 |
Completed |
Hospital de Clinicas de Porto Alegre |
2015-10-31 |
| NCT02695355 |
ERP Based Single-dose Predictions of Stimulants |
https://ClinicalTrials.gov/show/NCT02695355 |
Completed |
Ostfold Hospital Trust |
2013-01-31 |
| NCT02259517 |
An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD |
https://ClinicalTrials.gov/show/NCT02259517 |
Recruiting |
New York State Psychiatric Institute |
2020-07-31 |
| NCT02210728 |
Efficacy of Cognitive Behavioral Therapy in Treatment of Adults With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT02210728 |
Active, not recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2018-10-31 |
| NCT01322048 |
DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury |
https://ClinicalTrials.gov/show/NCT01322048 |
Completed |
Vanderbilt University Medical Center |
2015-01-31 |
| NCT03942835 |
Psychometric Validation of the Competitive Attention Test |
https://ClinicalTrials.gov/show/NCT03942835 |
Recruiting |
Hospices Civils de Lyon |
2024-01-21 |
| NCT00794040 |
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation |
https://ClinicalTrials.gov/show/NCT00794040 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-02-01 |
| NCT00783835 |
Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00783835 |
Completed |
Janssen-Cilag Farmaceutica Ltda. |
2008-10-31 |
| NCT00780208 |
Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD |
https://ClinicalTrials.gov/show/NCT00780208 |
Completed |
Medical University of South Carolina |
2008-10-31 |
| NCT00778310 |
Neuroimaging of the Effects of Concerta in the Treatment of ADHD |
https://ClinicalTrials.gov/show/NCT00778310 |
Completed |
The University of Texas Health Science Center at San Antonio |
2010-12-31 |
| NCT00776009 |
Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting. |
https://ClinicalTrials.gov/show/NCT00776009 |
Completed |
Novartis |
2008-12-31 |
| NCT00773916 |
The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00773916 |
Completed |
Federal University of Rio Grande do Sul |
2008-07-31 |
| NCT00772161 |
Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00772161 |
Completed |
University Hospital Freiburg |
2008-12-31 |
| NCT00760747 |
Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD) |
https://ClinicalTrials.gov/show/NCT00760747 |
Completed |
Eli Lilly and Company |
2010-08-31 |
| NCT00758160 |
The Impact of Osmotic Release Oral Delivery System Methylphenidate (OROS MPH) Upon Family of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00758160 |
Completed |
Johnson & Johnson Taiwan Ltd |
2008-06-30 |
| NCT00757029 |
Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) |
https://ClinicalTrials.gov/show/NCT00757029 |
Completed |
Hallym University Medical Center |
2008-08-31 |
| NCT00754208 |
Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children |
https://ClinicalTrials.gov/show/NCT00754208 |
Completed |
University of Nebraska |
2010-01-31 |
| NCT00753012 |
Cardiovascular Study of Lisdexamfetamine in Healthy and Hypertensive Attention Deficit Hyperactivity Disorder Adults |
https://ClinicalTrials.gov/show/NCT00753012 |
Completed |
Massachusetts General Hospital |
2011-03-31 |
| NCT00736255 |
Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study |
https://ClinicalTrials.gov/show/NCT00736255 |
Completed |
Duke University |
2011-07-31 |
| NCT00735371 |
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00735371 |
Completed |
Shire |
2009-04-30 |
| NCT00733356 |
The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading |
https://ClinicalTrials.gov/show/NCT00733356 |
Completed |
University of California, Irvine |
2009-09-30 |
| NCT00723190 |
Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00723190 |
Completed |
Shionogi Inc. |
2010-03-31 |
| NCT00716274 |
Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia |
https://ClinicalTrials.gov/show/NCT00716274 |
Completed |
Eli Lilly and Company |
2016-07-31 |
| NCT00714688 |
A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00714688 |
Completed |
Janssen-Cilag International NV |
2009-04-30 |
| NCT00704990 |
Combination Natural Health Product in Children With Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00704990 |
Completed |
The Canadian College of Naturopathic Medicine |
2009-12-31 |
| NCT00700427 |
A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00700427 |
Completed |
Eli Lilly and Company |
2011-08-31 |
| NCT00686933 |
Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00686933 |
Completed |
AbbVie |
2008-10-31 |
| NCT00640419 |
Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00640419 |
Completed |
AbbVie |
2008-07-31 |
| NCT00640185 |
Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00640185 |
Completed |
AbbVie |
2008-08-31 |
| NCT00636818 |
Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00636818 |
Completed |
Eli Lilly and Company |
2008-09-30 |
| NCT00632619 |
Group-Based Behavioral Therapy Combined With Stimulant Medication for Treating Children With Attention Deficit Hyperactivity Disorder and Impaired Mood |
https://ClinicalTrials.gov/show/NCT00632619 |
Completed |
Florida International University |
2011-06-30 |
| NCT00626236 |
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems |
https://ClinicalTrials.gov/show/NCT00626236 |
Completed |
Supernus Pharmaceuticals, Inc. |
2009-09-30 |
| NCT00619840 |
Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD |
https://ClinicalTrials.gov/show/NCT00619840 |
Completed |
Medice Arzneimittel Pütter GmbH & Co KG |
2006-05-31 |
| NCT00610441 |
Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003) |
https://ClinicalTrials.gov/show/NCT00610441 |
Completed |
Merck Sharp & Dohme Corp. |
2009-03-02 |
| NCT00586157 |
Study of Medication Patch to Treat Children Ages 6-12 With ADHD |
https://ClinicalTrials.gov/show/NCT00586157 |
Completed |
Massachusetts General Hospital |
2008-12-31 |
| NCT00585910 |
Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD |
https://ClinicalTrials.gov/show/NCT00585910 |
Completed |
Massachusetts General Hospital |
2007-12-31 |
| NCT00573534 |
Pilot Study of Vyvanseâ„¢ In ADHD Adolescents at Risk for Substance Abuse |
https://ClinicalTrials.gov/show/NCT00573534 |
Completed |
New York State Psychiatric Institute |
2010-01-31 |
| NCT00568685 |
Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00568685 |
Completed |
Eli Lilly and Company |
2008-11-30 |
| NCT00566449 |
A Safety and Effectiveness Study of JNJ-31001074 in Adults With Attention-Deficit/Hyperactivity Disorder. |
https://ClinicalTrials.gov/show/NCT00566449 |
Completed |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2008-07-31 |
| NCT00566371 |
The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents |
https://ClinicalTrials.gov/show/NCT00566371 |
Completed |
Rhode Island Hospital |
2008-12-31 |
| NCT00564954 |
A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00564954 |
Completed |
Novartis |
2007-11-30 |
| NCT00557960 |
ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD |
https://ClinicalTrials.gov/show/NCT00557960 |
Completed |
Shire |
NA |
| NCT00557011 |
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD |
https://ClinicalTrials.gov/show/NCT00557011 |
Completed |
New River Pharmaceuticals |
NA |
| NCT00556959 |
Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00556959 |
Completed |
Addrenex Pharmaceuticals, Inc. |
2008-08-31 |
| NCT00556296 |
Phase 3 Randomized Double-Blind Placebo-Controlled Study of NRP104 in Children Aged 6-12 With ADHD |
https://ClinicalTrials.gov/show/NCT00556296 |
Completed |
New River Pharmaceuticals |
NA |
| NCT00553319 |
Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence |
https://ClinicalTrials.gov/show/NCT00553319 |
Completed |
New York State Psychiatric Institute |
2013-07-31 |
| NCT00546910 |
Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00546910 |
Completed |
Eli Lilly and Company |
2009-05-31 |
| NCT00541346 |
A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms |
https://ClinicalTrials.gov/show/NCT00541346 |
Completed |
University of Oklahoma |
2009-05-31 |
| NCT00531752 |
A Study to Evaluate the Efficacy and Safety of Two Doses of PF-03654746 in Adults With Attention Deficit Hyperactivity Disorder (ADHD). |
https://ClinicalTrials.gov/show/NCT00531752 |
Completed |
Pfizer |
2008-09-30 |
| NCT00530335 |
Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00530335 |
Completed |
Eli Lilly and Company |
2008-04-30 |
| NCT00530257 |
Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory |
https://ClinicalTrials.gov/show/NCT00530257 |
Completed |
Children’s Hospital of Philadelphia |
2008-06-30 |
| NCT00528697 |
A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00528697 |
Completed |
AbbVie |
2008-04-30 |
| NCT00518232 |
A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00518232 |
Completed |
Johnson & Johnson Taiwan Ltd |
2007-06-30 |
| NCT00517504 |
Methylphenidate Study in Young Children With Developmental Disorders |
https://ClinicalTrials.gov/show/NCT00517504 |
Completed |
University of Arizona |
2008-03-31 |
| NCT00512291 |
Subcutaneous Olanzapine for Hyperactive or Mixed Delirium |
https://ClinicalTrials.gov/show/NCT00512291 |
Completed |
M.D. Anderson Cancer Center |
2007-08-31 |
| NCT00510276 |
Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes |
https://ClinicalTrials.gov/show/NCT00510276 |
Completed |
Eli Lilly and Company |
2009-02-28 |
| NCT00506285 |
Methylphenidate Transdermal System (MTS) in the Treatment of Adult ADHD |
https://ClinicalTrials.gov/show/NCT00506285 |
Completed |
University of Utah |
2009-04-30 |
| NCT00486083 |
Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD |
https://ClinicalTrials.gov/show/NCT00486083 |
Completed |
Eli Lilly and Company |
NA |
| NCT00485875 |
Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT00485875 |
Completed |
Eli Lilly and Company |
NA |
| NCT00485797 |
Effects of Ritalin on Postural Stability of Hyper Active Children |
https://ClinicalTrials.gov/show/NCT00485797 |
Completed |
Soroka University Medical Center |
2008-03-31 |
| NCT00485628 |
Safety Study in Outpatient Japanese Children With ADHD |
https://ClinicalTrials.gov/show/NCT00485628 |
Completed |
Eli Lilly and Company |
NA |
| NCT00485550 |
Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven’t Responded to Stimulant Therapy |
https://ClinicalTrials.gov/show/NCT00485550 |
Completed |
Eli Lilly and Company |
NA |
| NCT00485459 |
Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT00485459 |
Completed |
Eli Lilly and Company |
NA |
| NCT00483106 |
Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00483106 |
Recruiting |
McGill University |
2023-12-31 |
| NCT00482313 |
Efficacy and Effectiveness of Methylphenidate in Swedish Male Prison Inmates With Attention-deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00482313 |
Completed |
Psychiatry Karolinska |
2010-04-30 |
| NCT00475735 |
A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00475735 |
Completed |
Merck Sharp & Dohme Corp. |
2008-04-30 |
| NCT00471354 |
A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine |
https://ClinicalTrials.gov/show/NCT00471354 |
Completed |
Eli Lilly and Company |
2008-11-30 |
| NCT00467428 |
Efficacy and Safety of NS2359 in Adults With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00467428 |
Completed |
NeuroSearch A/S |
NA |
| NCT00466791 |
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD |
https://ClinicalTrials.gov/show/NCT00466791 |
Completed |
Noven Therapeutics |
2005-05-31 |
| NCT00447278 |
A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents |
https://ClinicalTrials.gov/show/NCT00447278 |
Completed |
Eli Lilly and Company |
2009-03-31 |
| NCT00444574 |
Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD |
https://ClinicalTrials.gov/show/NCT00444574 |
Completed |
Noven Therapeutics |
2005-06-30 |
| NCT00443391 |
A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00443391 |
Completed |
AbbVie |
2008-10-31 |
| NCT00434213 |
Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA |
https://ClinicalTrials.gov/show/NCT00434213 |
Completed |
Noven Therapeutics |
2007-08-31 |
| NCT00429273 |
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00429273 |
Completed |
University of California, Los Angeles |
2011-07-31 |
| NCT00429091 |
A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00429091 |
Completed |
Abbott |
2007-08-31 |
| NCT00428792 |
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00428792 |
Completed |
Novartis |
2007-12-31 |
| NCT00419445 |
Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00419445 |
Completed |
CoMentis |
2008-01-31 |
| NCT00418262 |
Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD |
https://ClinicalTrials.gov/show/NCT00418262 |
Completed |
University of Oklahoma |
2015-04-22 |
| NCT00418184 |
The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00418184 |
Completed |
Enzymotec |
2008-11-30 |
| NCT00417794 |
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD |
https://ClinicalTrials.gov/show/NCT00417794 |
Completed |
University of Oklahoma |
2015-04-22 |
| NCT00414921 |
Preschool Supplement to Clonidine in ADHD (Kiddie-CAT) |
https://ClinicalTrials.gov/show/NCT00414921 |
Completed |
University of Cincinnati |
NA |
| NCT00409708 |
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00409708 |
Completed |
Novartis |
2008-03-31 |
| NCT00406354 |
Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany |
https://ClinicalTrials.gov/show/NCT00406354 |
Completed |
Eli Lilly and Company |
2009-01-31 |
| NCT00399763 |
Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder |
https://ClinicalTrials.gov/show/NCT00399763 |
Completed |
Denver Health and Hospital Authority |
2008-02-29 |
| NCT00799487 |
CONCERTA Lab School Study |
https://ClinicalTrials.gov/show/NCT00799487 |
Completed |
Ortho-McNeil Janssen Scientific Affairs, LLC |
2009-06-26 |
| NCT00393042 |
Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR |
https://ClinicalTrials.gov/show/NCT00393042 |
Completed |
Seattle Children’s Hospital |
2009-02-28 |
| NCT00391729 |
A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00391729 |
Completed |
Abbott |
2007-06-30 |
| NCT00386581 |
Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00386581 |
Completed |
Eli Lilly and Company |
NA |
| NCT00382616 |
Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD |
https://ClinicalTrials.gov/show/NCT00382616 |
Completed |
Tel-Aviv Sourasky Medical Center |
NA |
| NCT00381758 |
The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting |
https://ClinicalTrials.gov/show/NCT00381758 |
Completed |
UCB Pharma |
2002-08-31 |
| NCT00381407 |
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00381407 |
Completed |
NYU Langone Health |
2011-02-28 |
| NCT00380692 |
Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder |
https://ClinicalTrials.gov/show/NCT00380692 |
Completed |
Eli Lilly and Company |
2008-05-31 |
| NCT00799409 |
Lab School Day Study for CONCERTA of Older Children With ADHD |
https://ClinicalTrials.gov/show/NCT00799409 |
Completed |
Ortho-McNeil Janssen Scientific Affairs, LLC |
2009-06-30 |
| NCT00356070 |
Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison |
https://ClinicalTrials.gov/show/NCT00356070 |
Completed |
Norwegian University of Science and Technology |
2006-12-31 |
| NCT00343811 |
Study to Evaluate the Efficacy of Modafinil Treatment in Patients With Attention Deficit Hyperactivity Disorder (ADHD) Who Are Responders to Modafinil Treatment |
https://ClinicalTrials.gov/show/NCT00343811 |
Completed |
Teva Pharmaceutical Industries |
NA |
| NCT00337285 |
An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00337285 |
Completed |
New River Pharmaceuticals |
2007-11-30 |
| NCT00334880 |
Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00334880 |
Completed |
New River Pharmaceuticals |
NA |
| NCT00326391 |
A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00326391 |
Completed |
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. |
2006-12-31 |
| NCT00326300 |
A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00326300 |
Completed |
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. |
NA |
| NCT00323947 |
Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy |
https://ClinicalTrials.gov/show/NCT00323947 |
Completed |
Boston Children’s Hospital |
2007-11-30 |
| NCT00320528 |
Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00320528 |
Completed |
Eli Lilly and Company |
2008-10-31 |
| NCT00318448 |
Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia |
https://ClinicalTrials.gov/show/NCT00318448 |
Completed |
Sanofi |
2006-08-31 |
| NCT00316290 |
Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00316290 |
Completed |
University of Maryland, College Park |
2010-12-31 |
| NCT00315276 |
Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD |
https://ClinicalTrials.gov/show/NCT00315276 |
Completed |
Teva Pharmaceutical Industries |
NA |
| NCT00307684 |
Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00307684 |
Completed |
Janssen-Cilag International NV |
2008-07-31 |
| NCT00305370 |
Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD |
https://ClinicalTrials.gov/show/NCT00305370 |
Completed |
Federal University of Rio Grande do Sul |
2008-01-31 |
| NCT00304681 |
An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children |
https://ClinicalTrials.gov/show/NCT00304681 |
Completed |
Janssen-Ortho Inc., Canada |
NA |
| NCT00291070 |
Effects of L-Theanine in Boys With ADHD |
https://ClinicalTrials.gov/show/NCT00291070 |
Completed |
University of British Columbia |
2006-07-31 |
| NCT00278473 |
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults |
https://ClinicalTrials.gov/show/NCT00278473 |
Completed |
Icahn School of Medicine at Mount Sinai |
2008-10-31 |
| NCT00269815 |
Long-term Safety and Effectiveness of OROS Methylphenidate HCl in Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00269815 |
Completed |
Alza Corporation, DE, USA |
NA |
| NCT00269802 |
A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00269802 |
Completed |
Alza Corporation, DE, USA |
NA |
| NCT00269789 |
A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children |
https://ClinicalTrials.gov/show/NCT00269789 |
Completed |
Alza Corporation, DE, USA |
NA |
| NCT00269776 |
An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00269776 |
Completed |
Alza Corporation, DE, USA |
NA |
| NCT00267605 |
Strongest Families (Formerly Family Help Program): Pediatric Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00267605 |
Completed |
IWK Health Centre |
2006-06-30 |
| NCT00257725 |
Long Duration Stimulant Treatment Study of Preschoolers With ADHD-Feasibility Study |
https://ClinicalTrials.gov/show/NCT00257725 |
Completed |
New York State Psychiatric Institute |
2008-03-31 |
| NCT00254462 |
Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children |
https://ClinicalTrials.gov/show/NCT00254462 |
Completed |
University of Nebraska |
2008-08-31 |
| NCT00249353 |
An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00249353 |
Completed |
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. |
NA |
| NCT00248092 |
Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse |
https://ClinicalTrials.gov/show/NCT00248092 |
Completed |
New River Pharmaceuticals |
NA |
| NCT00247572 |
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories |
https://ClinicalTrials.gov/show/NCT00247572 |
Completed |
New River Pharmaceuticals |
NA |
| NCT00246220 |
A Study of the Effectiveness and Safety of Prolonged-release Methylphenidate Hydrochloride in Adult Patients With Attention Deficit/Hyperactivity Disorder. |
https://ClinicalTrials.gov/show/NCT00246220 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
NA |
| NCT00246207 |
CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults |
https://ClinicalTrials.gov/show/NCT00246207 |
Completed |
Janssen-Ortho Inc., Canada |
NA |
| NCT00228046 |
Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00228046 |
Completed |
Stony Brook University |
2007-07-31 |
| NCT00221962 |
Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder) |
https://ClinicalTrials.gov/show/NCT00221962 |
Completed |
University Hospitals Cleveland Medical Center |
2007-04-30 |
| NCT00218543 |
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00218543 |
Completed |
New York State Psychiatric Institute |
2007-03-31 |
| NCT00218322 |
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD |
https://ClinicalTrials.gov/show/NCT00218322 |
Completed |
Massachusetts General Hospital |
2006-03-31 |
| NCT00216918 |
Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder. |
https://ClinicalTrials.gov/show/NCT00216918 |
Completed |
Eli Lilly and Company |
NA |
| NCT00214981 |
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT00214981 |
Completed |
Teva Pharmaceutical Industries |
2006-09-30 |
| NCT00202605 |
Safety and Efficacy of SPD465 in Adults With ADHD |
https://ClinicalTrials.gov/show/NCT00202605 |
Completed |
Shire |
NA |
| NCT00192023 |
An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). |
https://ClinicalTrials.gov/show/NCT00192023 |
Completed |
Eli Lilly and Company |
2006-08-31 |
| NCT00191945 |
Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00191945 |
Completed |
Eli Lilly and Company |
2008-02-29 |
| NCT00191906 |
Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD) |
https://ClinicalTrials.gov/show/NCT00191906 |
Completed |
Eli Lilly and Company |
2007-12-31 |
| NCT00191880 |
Open-Label Trial of Atomoxetine to Evaluate Academic Outcome in Children Ages 8-11 Years With Attention Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00191880 |
Completed |
Eli Lilly and Company |
NA |
| NCT00191737 |
An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00191737 |
Completed |
Eli Lilly and Company |
NA |
| NCT00191698 |
Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD |
https://ClinicalTrials.gov/show/NCT00191698 |
Completed |
Eli Lilly and Company |
2005-06-30 |
| NCT00191659 |
Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents |
https://ClinicalTrials.gov/show/NCT00191659 |
Completed |
Eli Lilly and Company |
NA |
| NCT00191633 |
Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes |
https://ClinicalTrials.gov/show/NCT00191633 |
Completed |
Eli Lilly and Company |
NA |
| NCT00191542 |
Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents |
https://ClinicalTrials.gov/show/NCT00191542 |
Completed |
Eli Lilly and Company |
NA |
| NCT00191516 |
An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00191516 |
Completed |
Eli Lilly and Company |
NA |
| NCT00191386 |
Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD) |
https://ClinicalTrials.gov/show/NCT00191386 |
Completed |
Eli Lilly and Company |
2009-08-31 |
| NCT00191295 |
Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00191295 |
Completed |
Eli Lilly and Company |
NA |
| NCT00191048 |
Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD |
https://ClinicalTrials.gov/show/NCT00191048 |
Completed |
Eli Lilly and Company |
NA |
| NCT00190931 |
A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00190931 |
Completed |
Eli Lilly and Company |
NA |
| NCT00190775 |
A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00190775 |
Completed |
Eli Lilly and Company |
2009-07-31 |
| NCT00190684 |
Long-Term, Open Label Atomoxetine Study |
https://ClinicalTrials.gov/show/NCT00190684 |
Completed |
Eli Lilly and Company |
2009-10-31 |
| NCT00183391 |
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children |
https://ClinicalTrials.gov/show/NCT00183391 |
Completed |
Icahn School of Medicine at Mount Sinai |
2011-06-30 |
| NCT00179894 |
Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings |
https://ClinicalTrials.gov/show/NCT00179894 |
Completed |
Ann & Robert H Lurie Children’s Hospital of Chicago |
2009-07-31 |
| NCT00178503 |
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children |
https://ClinicalTrials.gov/show/NCT00178503 |
Completed |
The University of Texas Health Science Center, Houston |
2011-05-31 |
| NCT00174226 |
Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar |
https://ClinicalTrials.gov/show/NCT00174226 |
Completed |
Pfizer |
NA |
| NCT00152035 |
Safety of SPD465 in Treating Adults With ADHD. |
https://ClinicalTrials.gov/show/NCT00152035 |
Completed |
Shire |
NA |
| NCT00152022 |
Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD. |
https://ClinicalTrials.gov/show/NCT00152022 |
Completed |
Shire |
NA |
| NCT00152009 |
Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17 |
https://ClinicalTrials.gov/show/NCT00152009 |
Completed |
Shire |
2006-03-31 |
| NCT00151996 |
Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00151996 |
Completed |
Shire |
2006-05-31 |
| NCT00151970 |
Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD |
https://ClinicalTrials.gov/show/NCT00151970 |
Completed |
Noven Therapeutics |
2006-10-31 |
| NCT00151957 |
Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials |
https://ClinicalTrials.gov/show/NCT00151957 |
Completed |
Noven Therapeutics |
2007-06-30 |
| NCT00150618 |
Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17 |
https://ClinicalTrials.gov/show/NCT00150618 |
Completed |
Shire |
2006-05-31 |
| NCT00150592 |
Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17 |
https://ClinicalTrials.gov/show/NCT00150592 |
Completed |
Shire |
2006-04-30 |
| NCT00150579 |
Efficacy and Safety of SPD465 in Adults With ADHD |
https://ClinicalTrials.gov/show/NCT00150579 |
Completed |
Shire |
NA |
| NCT00142961 |
Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00142961 |
Completed |
New York State Psychiatric Institute |
2007-01-31 |
| NCT00819611 |
Working Memory Training in Young ADHD Children |
https://ClinicalTrials.gov/show/NCT00819611 |
Completed |
Radboud University |
2013-05-31 |
| NCT00118911 |
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00118911 |
Completed |
Massachusetts General Hospital |
2009-07-31 |
| NCT00116259 |
Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00116259 |
Completed |
Federal University of Rio Grande do Sul |
2008-01-31 |
| NCT00819429 |
Supplements and Social Skills Intervention Study |
https://ClinicalTrials.gov/show/NCT00819429 |
Completed |
National Healthcare Group, Singapore |
2014-06-30 |
| NCT00100295 |
Herbal Treatment for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00100295 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00071656 |
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I |
https://ClinicalTrials.gov/show/NCT00071656 |
Completed |
University of California, San Francisco |
NA |
| NCT00050622 |
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD) |
https://ClinicalTrials.gov/show/NCT00050622 |
Completed |
Florida International University |
2004-08-31 |
| NCT00050050 |
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder |
https://ClinicalTrials.gov/show/NCT00050050 |
Completed |
Massachusetts General Hospital |
2003-08-31 |
| NCT00048360 |
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults |
https://ClinicalTrials.gov/show/NCT00048360 |
Completed |
GlaxoSmithKline |
2003-06-30 |
| NCT00031395 |
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children |
https://ClinicalTrials.gov/show/NCT00031395 |
Completed |
University of Cincinnati |
NA |
| NCT00025779 |
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders |
https://ClinicalTrials.gov/show/NCT00025779 |
Completed |
National Institute of Mental Health (NIMH) |
2003-11-30 |
| NCT00018863 |
Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS) |
https://ClinicalTrials.gov/show/NCT00018863 |
Active, not recruiting |
New York State Psychiatric Institute |
2006-03-31 |
| NCT00730249 |
Quality Assurance of Administering Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) - QUMEA |
https://ClinicalTrials.gov/show/NCT00730249 |
Completed |
Medice Arzneimittel Pütter GmbH & Co KG |
2010-01-31 |
| NCT00012584 |
Treatment of Youth With ADHD and Anxiety |
https://ClinicalTrials.gov/show/NCT00012584 |
Completed |
National Institute of Mental Health (NIMH) |
2002-05-31 |
| NCT00000388 |
Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA) |
https://ClinicalTrials.gov/show/NCT00000388 |
Completed |
NYU Langone Health |
NA |